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Abstract: Accurate predictions of free energies of binding of ligands to proteins are challenging 
partly because of the non-additivity of protein-ligand interactions, i.e. the free energy of binding 
is the sum of numerous enthalpic and entropic contributions that cannot be separated into 
functional group contributions. In principle molecular simulations methodologies that compute 
free energies of binding do capture non-additivity of protein-ligand interactions, but efficient 
protocols are necessary to compute well-converged free energies of binding that clearly resolve 
non-additive effects. To this end an efficient GPU-accelerated implementation of alchemical free 
energy calculations has been developed and applied to two congeneric series of ligands of the 
 2 
enzyme thrombin. The results show that accurate binding affinities are computed across the two  
congeneric series and positive coupling between non polar R
1
 substituents and a X=NH3
+
 
substituent is reproduced, albeit with a weaker trend than experimentally observed. By contrast a 
docking methodology completely fails to capture non-additive effects. Further analysis shows 
that the non-additive effects are partly due to variations in the strength of a hydrogen-bond 
between the X=NH3
+ 
ligands family and thrombin residue Gly216. However other partially 
compensating interactions occur across the entire binding site and no single interaction dictates 
the magnitude of the non-additive effects for all the analysed protein-ligand complexes.  
Introduction 
 
A significant component of pre-clinical drug discovery is the optimization of the non-covalent 
binding between a disease-involved protein and small organic molecules.
1–3
 To this end, the free 
energy of binding is frequently used to quantify the strength of protein-ligand interactions. 
Separating the free energy of binding in enthalpic and entropic components indicates that potent 
ligands may be obtained by minimizing the enthalpy of binding while maximizing the entropy of 
binding. Binding enthalpies result from a competition between two concomitant effects: Van der 
Waals (VdW) and electrostatic interactions, and the desolvation of polar groups.
4
 VdW 
interactions are optimised by the shape complementarity between the protein and the ligand, 
whereas electrostatic interactions are optimised via charge and hydrogen bonding interactions 
between donor and acceptor atoms in the protein-ligand complex
5
. The desolvation of polar 
groups reflects the strength of the interactions between the solvent and the protein/ligand, before 
formation of the protein-ligand complex. A favourable enthalpy change upon binding is an 
indication of sufficiently strong VdW/electrostatic interactions between the target and the ligand 
 3 
that compensate for the unfavourable enthalpy change associated with desolvation
5
. Binding 
entropies arise from two major terms: conformational entropy changes and solvation entropy 
changes. The former is related to changes in probability distributions of translational, rotational 
and internal degrees of freedom of the ligand and protein upon complex formation, while the 
latter depends on differences in the probability distributions of translational and rotational 
degrees of freedom of the water molecules that solvate the protein, the ligand, and the complex.
5–
7
 
In this intricate framework, medicinal chemists are usually tasked to identify structural 
modifications of a ligand that will optimise all the above contributions to the free energy of 
binding. This is frequently pursued through iterative Structure-Activity Relationship (SAR) 
studies where individual moieties of a ligand are optimised sequentially.
8,9
 A major 
simplification implicit in this approach is the additivity of the binding free energy, i.e. the 
assumption that binding free energies can be decomposed into a sum of independent components 
ascribed to specific parts of the system.  Many popular molecular modelling methods also make 
this assumption, for instance Matched Molecular Pair Analysis (MMPS),
10
 Free-Wilson 
Analysis,
11
 scoring function approaches and linear QSAR models.
12
 
In general, if the cruel question is: “can free energy be decomposed into a sum of 
independent components ascribed to specific parts in a system?”, then the answer is negative.  
Free energy is a property of the whole of phase space and its decomposition in components holds 
only if phase space is divisible into independent parts. This result has been reported several times 
in the literature.
13–15
 Assuming for simplicity a canonical ensemble, the Helmholtz free energy F 
of a thermodynamic system at temperature T and Hamiltonian H is given by:  
𝐹 = −𝑘𝑏𝑇 ln⟨𝑒
−𝛽𝐻⟩
𝑁𝑉𝑇
 ,      (1) 
 4 
where = 1/kbT,  kb is the Boltzmann constant, and the symbol <> denotes a canonical ensemble 
average. If the Hamiltonian H can be separated into for instance two independent components 
one can write equation 2:  
𝐻(𝑞1, 𝑞2; 𝑝1,𝑝2) =  ?̃?1(𝑞1; 𝑝1) + ?̃?2(𝑞2; 𝑝2) ,    (2) 
where it is implied that q1, p1, q2 and p2 are uncoupled position and momenta coordinates, then 
(and only then) it follows that:
13
 
𝐹 = −𝑘𝑏𝑇 ln⟨𝑒
−𝛽?̃?1𝑒−𝛽?̃?2⟩
𝑁𝑉𝑇
= −𝑘𝑏𝑇 ln⟨𝑒
−𝛽?̃?1⟩
𝑁𝑉𝑇
−𝑘𝑏𝑇 ln⟨𝑒
−𝛽?̃?2⟩
𝑁𝑉𝑇
=  𝐹1 + 𝐹2
 (3) 
The extent to which the additivity assumption in eq 3 may be valid in practice is a question 
that is of central importance in many chemical contexts. Patel et al.
16
 investigated 19 different 
protein targets to examine the extent of non-additive substituent effects on ligands binding 
affinities and found that only half of the targets exhibited approximately additive behaviour. 
Thus, while in theory it is incorrect to expect that free energies of binding may be decomposed 
into independent components; in practice additivity of protein-ligand interactions may be a good 
approximation in some instances. It follows that it is desirable to formulate molecular models 
that may reproduce, and elucidate, non-additive effects in protein-ligand interactions. 
A detailed study of non-additivity of functional group contributions to protein-ligand 
interactions was reported by Baum et al.
17
 The work featured isothermal titration calorimetry 
(ITC) measurements and crystallographic analyses of the enzyme thrombin in complex with 
different series of congeneric inhibitors. Structurally the ligand binding site in thrombin presents 
three sub-pockets illustrated in Figure 1A. The ligands may be classified in two series that shall 
be referred to as series 3 (X=H) and series 5 (X=NH3
+
) for consistency with the notation used by 
 5 
Baum et al. The amino group of series 5 ligands forms a charged assisted hydrogen-bond with 
the backbone carbonyl of Gly216. Each series also features variations in the nature of the R
1
 
group that fills the S1 pocket.
17
 Other series were reported, but are not the focus of the present 
study. Baum et al. demonstrated coupling between the X and R
1
 substituents since the standard 
free energy of binding of series 5 ligands is more favourable than series 3 ligands with equivalent 
R
1
 groups (Figure 1B). Correlation of structural data from X-ray diffracted crystals and 
calorimetric data suggested that the non-additivity was correlated to changes in hydrogen-
bonding distances between the ligands and the backbone of Gly216, changes in residual mobility 
of the ligands, and changes in packing interactions with S3 pocket residues.  
Which of these factors dominate non-additivity in this context remains uncertain owing to the 
difficulty of disentangling cause and effects from the experimental data. Also given potential 
pitfalls in relating structural and dynamical measurements from X-ray diffracted crystals to 
protein-ligand interactions in aqueous conditions,
18
 further insights into plausible non-additivity 
mechanisms is desirable, and this was here sought by means of molecular simulations.   
Materials and Methods 
Protein structure setup 
The crystallographic structure of human thrombin in a complex with a thrombin ligand 
structurally related to the ligands simulated in this study was downloaded from the PDB 
databank
19
 (PDB code 2ZC9
17
). The protein structure was inspected and prepared for molecular 
simulations using Maestro.
20
 The hirugen chain was removed from the structure. The side chain 
of Arg75 in the heavy chain (chain H) of thrombin was partially resolved.
19
 Missing atoms were 
added to complete the side-chain in a solvent exposed conformation.
19
 The incomplete light 
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chain was capped before Glu1C with an ACE residue and after Ile14L with an NME residue.
19
 
The incomplete heavy chain was capped after Gly246 with an NME residue.
19
 Missing residues 
Trp148, Thr149, Ala149A, Asn149B, Val149C, Gly149D, Lys149E in chain H were modeled in 
the structure using the FALC-Loop web server
21
. Standard protonation states were assumed for 
protein side-chains
19
. On the basis of visual inspection of hydrogen bonding patterns, His57 and 
His71 were modeled in their uncharged δ-tautomer. His91, His119 and His230 were modeled in 
the δ-tautomer19. Disulfide bridges were modeled between Cys42-Cys58, Cys1-Cys122, Cys168-
Cys182 and Cys191-Cys220
19
.  
Ligands structure setup 
In this investigation all the thrombin inhibitors in the 3 and 5 series reported by Baum et al. 
study were considered (Figure 1).
17
 The ligands in the 3 and 5 series were modeled using the 
software Maestro,
20
 and manually placed inside the binding site in a starting conformation 
selected according to available crystallographic data reported by Baum et al., and visual 
inspection. In addition, the amino group X=NH3
+
 for each ligand in the 5 series was protonated 
for consistency with the in vitro assay conditions.  
Molecular simulations setup  
In order to assemble input files used as starting conformations for subsequent calculations the 
FESetup software package was used.
22
 The following protocol was set in FESetup for the 
automated preparation of the ligands, protein and complexes input files: 
Ligands: The atomic charges were assigned by using Antechamber
23
 (as implemented in 
Amber 11), selecting the AM1-BCC method.
24
 The GAFF force field was used for the generation 
of the remaining force field parameters.
23,25
 The Leap software was instructed to solvate ligands 
in a buffer of TIP3P water molecules,
26
 and counter-ions were added for the resulting systems to 
 7 
yield a net charge of zero.
27
 The solvated systems were energy minimized for 100 cycles by 
using the steepest descent method and equilibrated at 300 K and 1 atm pressure for 10
5
 MD steps 
with a 2 fs time step using the Amber module Sander. During the equilibration stage, the ligands 
were restrained to their starting positions using a harmonic potential with a force constant of 10 
kcal mol
−1
 Å
−2
 and constraining all the hydrogen bonds to their equilibrium distances. 
Protein: The Amber ff99SB force field parameters were used to parameterize the protein.
28
 
The protein was energy minimized in vacuum for 500 cycles of steepest descent method by using 
the Amber module Sander. 
Protein-ligand complexes: The ligands were combined with the thrombin protein model and 
solvated in a buffer of TIP3P water molecules,
26
 and counter ions were also added to neutralize 
the solution.
27
 The complexes were energy minimized for 500 cycles by using the steepest 
descent method and equilibrated at 300 K and 1 atm pressure for 10
5
 MD steps with 2 fs time 
step via the Amber module Sander. During the equilibration stage, the protein and the ligands 
were restrained to their starting positions using a harmonic potential with a force constant of 10 
kcal•mol−1•Å−2 and constraining all the hydrogen bonds to their equilibrium distances. 
Protein-morph complexes and solvated morphs:  A single topology alchemical free energy 
calculation protocol was adopted in this study (see below). Thus coordinates and parameters for 
morph molecules that map between pairs of ligands were generated by the software FESetup.
22
 
Instructions to download all input files generated by the procedure are given in the Supporting 
Information. 
Molecular simulations protocols 
Figure 2 illustrates the strategy used to study non-additive effects in series 3 and 5 
respectively. The symbols 5R’ and 5R’’ denote ligands with X=NH3
+
 and R
1=R’ or R’’ 
substituents. Similarly, the symbols 3R’ and 3R’’ denote ligands with X=H and R1=R’ or R’’ 
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substituents.  The non-additivity level (NA) quantity in the isothermal-isobaric ensemble was 
defined as follows:  
𝑁𝐴 =  ∆∆𝐺𝑏𝑖𝑛𝑑(5R
′ → 5R′′) −  ∆∆𝐺𝑏𝑖𝑛𝑑(3R
′ → 3R′′) ,    (4) 
where ∆∆𝐺𝑏𝑖𝑛𝑑(5R
′ → 5R′′) − and ∆∆𝐺𝑏𝑖𝑛𝑑(3R
′ → 3R′′) are the binding free energies of 5R’’ 
and 3R’’ relative to 5R’ and 3R’ respectively. If NA equates zero then the nature of the group X 
does not influence the interactions of R’ or R’’, otherwise NA quantifies the extent of positive or 
negative coupling between the interactions of X and R’/R’’.  
Equation (4) shows that in order to compute non-additivity levels it is necessary to calculate 
the relative binding free energy between the different ligands in the two series. Each binding free 
energy of a ligand B relative to a ligand A is the difference of two computed free energy changes 
given by: 
 ∆∆𝐺𝑏𝑖𝑛𝑑(𝐀 → 𝐁) =  ∆𝐺𝑝𝑟𝑜𝑡(𝐀 → 𝐁) − ∆𝐺𝑤𝑎𝑡(𝐀 → 𝐁) ,    (5) 
where ∆𝐺𝑝𝑟𝑜𝑡(𝐀 → 𝐁) is the computed free energy change for morphing a ligand A into a ligand 
B in the solvated protein binding site, and ∆𝐺𝑤𝑎𝑡(𝐀 → 𝐁) is the computed free energy change for 
morphing ligand A into B in an aqueous environment.
29,30
 The starting and final ligands used to 
compute the relative binding affinities in this study are reported in Figure 3. The ligands 3B and 
5B were selected as reference end-state most of the time because these ligands were the most 
central in the network of the defined alchemical transformations.  
Similarly, it is also possible to define the contribution of components of the potential energy 
function to non-additivity levels. For instance, for protein-ligand interaction energies: 
𝑁𝐴𝑐𝑜𝑛𝑡(𝑈𝑃𝐿) =  [〈𝑈𝑃𝐿(5R
′′)〉 − 〈𝑈𝑃𝐿(5R
′)〉] − [〈𝑈𝑃𝐿(3R
′′)〉 − 〈𝑈𝑃𝐿(3R
′)〉] ,   (6) 
where UPL is the protein-ligand interaction energy, and the brackets denote ensemble averages.  
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Equation (4) indicates that non-additivity levels result from differences in two relative free 
energies of binding. This implies that precise measurements of non-additivity levels require two 
well converged relative binding free energies. Given the potentially slow convergence of these 
quantities it was deemed important to achieve high-performance in conformational sampling to 
produce well-converged free energies. To this end an ad-hoc implementation based on the 
alchemical single topology method was developed to calculate the relative binding free energies 
of the thrombin ligands. The implementation extended the molecular simulation library Sire
31
, 
 through linking to the OpenMM API.
32
 This API is able to implement Molecular Dynamics 
(MD) algorithms by using CUDA and OpenCL architectures present on the latest Graphic 
Processing Units (GPUs) and gain significant computational power compared to more 
conventional approaches.
33–35
  
The ligand mutations in both environments were performed by using the single topology 
method as implemented in the software package Sire release 2270. The coupling parameter λ 
used to mutate the ligands in both environments was modulated in the λ range [0, 1] where, λ = 0 
maps the morph molecule to ligand A, and λ= 1 maps the morph molecule to ligand B. The 
transformations were performed selecting 16 λi values (0.00000, 0.00616, 0.02447, 0.07368, 
0.11980, 0.19045, 0.28534, 0.40631, 0.57822, 0.70755, 0.80955, 0.88020, 0.92632, 0.97553, 
0.99384 and 1.00000). The λi values were chosen to concentrate at the beginning and end of the 
integration interval to improve numerical stability of the polynomial regression technique used to 
estimate free energy changes (see below).
36
  
In the single-topology implementation done here, the intra- and inter- molecular force field 
parameters involved in the mutations were linearly interpolated between the starting and final 
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ligand mutant parameters. In order to circumvent steric clashes at the end points of the 
simulations a soft core potential was used for non-bonded interactions of atoms that can be 
created or annihilated.
37
 The n and d parameters that control the rate of softening of Coulombic 
and Lennard-Jones interactions in the equation 3 of ref 37 were respectively set to 0 and 2.0.  
Free energy changes were calculated by using the thermodynamic integration method:
38,39
  
 Δ𝐺(𝐀 → 𝐁) = ∫
𝑑𝐺
𝑑𝜆
1
0
𝑑𝜆 ,      (7) 
where the integral in eq 7 was numerically estimated by using a polynomial interpolation of 
seventh-order.
36
 The free energy gradients at each selected 𝜆𝑖 value were approximated by using 
a finite difference approach:
40
 
 
𝑑𝐺
𝑑𝜆
≃
Δ𝐺(𝜆→𝜆+Δ𝜆)−Δ𝐺(𝜆→𝜆−Δ𝜆) 
2Δ𝜆
 ,     (8) 
where the delta increment was set to ∆λ = 10−3.  The free energy changes Δ𝐺(𝜆 → 𝜆 ± Δ𝜆) were 
calculated by using the Zwanzig equation given by eq 9:
41
 
 Δ𝐺(𝜆 → 𝜆 ± Δ𝜆) =  −1/𝛽 ln < 𝑒−𝛽(𝑈(𝜆±Δ𝜆)−𝑈(𝜆)) >𝜆   (9) 
where U is the total system potential energy and <>𝜆 denotes the ensemble average at the 
selected  value. Contribution of pressure-volume changes were neglected in eq 9. For the 
evaluation of free energy gradients at =0.0 and =1.0 assumptions were made that Δ𝐺(𝜆 → 𝜆 −
Δ𝜆) = −Δ𝐺(𝜆 → 𝜆 + Δ𝜆) and Δ𝐺(𝜆 → 𝜆 + Δ𝜆) = −Δ𝐺(𝜆 → 𝜆 − Δ𝜆). 
For each  value the ensemble average was computed by sampling the system using MD 
as implemented in Sire via the OpenMM API release 5.2. The OpenCL platform was used 
throughout. In production runs, each window was sampled for 10 ns using the NPT ensemble 
by setting the pressure and the temperature respectively to 1 atm and 300 K. The pressure was 
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regulated using a Monte Carlo Barostat with an update frequency of 25 MD steps,
42,43
 and the 
Andersen Thermostat was used to keep the temperature constant,
44
 selecting a collision 
frequency of 10 ps
−1
. The simulations were time evolved by using a Leapfrog-Verlet integrator 
with a 2 fs time step. All bonds involving hydrogens were constrained to their equilibrium 
distances. Non-bonded interactions were evaluated by using an atom-based cut off scheme 
setting the cutoff distance to 10 Å. Long-range electrostatic interactions were calculated by using 
an atom-based Barker-Watts reaction field,
45
 with the medium dielectric constant set to the water 
dielectric constant (εsolvent = 78.3).
46
 A total of 5 × 10
4
 gradient values were collected over 10 ns 
simulations for each  value and each protein-ligand complex calculation was repeated at least 
three times per ligand. At the beginning of each repeated run the particle velocities were 
randomly generated accordingly to the Maxwell-Boltzmann distribution at a temperature of 300 
K. In order to circumvent steric clashes at the beginning of the production runs due to 
modifications of the ligand parameters via changes in λ, each starting structure was energy 
minimized for 500 steps and re-equilibrated. This was done incrementing λ in steps of 0.1 until 
the desired target value was reached. Each intermediate λ value was equilibrated for 2 ps using a 
0.5 fs time step, keeping pressure and temperature set to 1 atm and 300 K. At the end of the re-
equilibration stage the time step was re-set to 2 fs. All the production runs were performed on an 
in-house GPU cluster of nVidia Tesla M2090 graphic card units, and the Blue Crystal GPU 
cluster of nVidia Tesla K20 graphic card units.  Instructions to download sample simulation 
scripts are provided in the Supporting Information.  
B-factors analyses 
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B-factors for ligand atoms were computed from the simulations in order to quantify ligand 
mobility in the thrombin binding site. This was done using equation 10 for selected ligand heavy 
atoms:   
 𝐵 =
8𝜋2
3
〈∆𝑟2〉 ,        (10) 
where  r2  is the mean square of the atomic displacement averaged over a molecular dynamics 
trajectory, after rigid body alignment against a reference coordinate. The reference coordinate 
was taken to be the average atomic position recorded along the trajectory. This analysis was 
performed for the end-states (=0 and =1) of each free energy calculation and ligand B-factors 
were computed by averaging results from all individual trajectories.  
Correlation errors analysis 
The extent to which uncertainties in measured and computed quantities influence statistical 
metrics used to evaluate correlations between experiment and measurements should be carefully 
assessed to determine the relevance of the results. This was done here using an error analysis 
procedure described below.
47,48
 
The experimental 𝑒𝑖 and the predicted 𝑝𝑖  relative binding free energies related to the ligand 
𝑖 ∈ {1, … , 𝑁} (N is the total number of the ligands) can be represented as the sets {… , 𝑒𝑖 ±
Δ𝑒𝑖, … } and {… , 𝑝𝑖 ± Δ𝑝𝑖 , … }, where Δ𝑒𝑖 and Δ𝑝𝑖 are respectively the experimental and predicted 
statistical uncertainties. It is assumed that the measured relative binding affinities are normally 
distributed and, therefore, for each data point 𝑒𝑖 and 𝑝𝑖 it is possible to generate new data points 
𝑒?̃? and 𝑝?̃? drawing from a normal distribution 𝑒𝑖 ̃~ 𝑁(𝜇 = 𝑒𝑖, 𝜎
2 = ∆𝑒𝑖) and 𝑝?̃? ~ 𝑁(𝜇 = 𝑝𝑖 , 𝜎
2 =
∆𝑝𝑖).   
For each pair sets {… , (𝑒𝑖, ?̃?𝑖), … } (Experimental-Experimental), {… , (𝑝𝑖 , ?̃?𝑖), … }  (Predicted-
Predicted) and {, … (𝑒𝑖, ?̃?𝑖), … } (Experimental-Predicted) it is possible to determine R
2 
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(coefficient of determination), MUE (mean unsigned error) and PI (predictive indices
6
) metrics. 
Iterating the procedure n times yields probability distributions 𝑓𝑅2, 𝑓𝑀𝑈𝐸  and 𝑓𝑃𝐼  of these metrics.  
A confidence interval in the metrics may then be obtained by plotting the resulting probability 
distributions and choosing lower a and upper b values of the associated cumulative probability 
functions F. Here probability distributions f were computed by re-sampling the sets n = 10
6
 
times, and a 95% confidence interval was chosen setting 𝑎 = 𝐹−1(0.03) and 𝑏 = 𝐹−1(0.98).  
Protein-ligand docking protocols 
The free energies of binding of the thrombin ligands were also estimated by using the 
docking software Autodock Vina.
49
 This was done to compare the results of the molecular 
simulations with molecular modelling protocols that do not explicitly consider protein dynamics 
and hydration.  The same protein structure was used for docking calculations. A grid of 20 Å × 
20 Å × 20 Å was centered on the thrombin binding site and a docking pose was generated for 
each ligand. The protein was kept rigid in all docking calculations. In all instances where 
comparison was possible, it was verified that Vina produced a binding pose very similar to the 
available experimental data. The Vina predicted binding affinity of the best scoring pose was 
used for subsequent analyses. 
Results and Discussion 
Precision and consistency of the computed free energies of binding 
Analysis of intermediate results showed that increasing the length of per- simulation time 
from 5 ns to 10 ns did not produce significant changes in the calculated Gwat(AB) values. 
Thus statistical uncertainties for these quantities were determined by using block averaging of 
the data collected with the 10 ns per- simulation protocol. To evaluate ∆Gprot(AB) triplicate 
runs of 10 ns per- each were performed, and the final ∆Gprot(AB) estimate was taken as the 
 14 
mean computed free energy change, and uncertainties taken as the standard error of the mean. 
Average free energy changes Gwat(AB), ∆Gprot(AB) and relative binding free energies 
Gbind (AB) for each perturbation AB are reported in Table S1 and S2 and compared with 
experimental data. With this protocol the maximum uncertainty on the predicted relative binding 
affinities Gbind (AB) was ca. 0.2-0.4 kcal/mol. The noisier results in the 3 series involved 
the ligand 3J and in the 5 series the ligands 5J and 5I. The alchemical transformation involving 
these ligands typically required a high number of atoms to be converted into dummy atoms, e.g. 
in the transformation 5J to 5B 14 atoms were transformed from a fully interacting to a dummy 
state. Large changes in ligand-excluded volume are associated with larger fluctuations of the free 
energy gradients.  
Consistency and reliability of the computed relative binding free energies was also assessed by 
considering thermodynamic cycle closures. These are frequently used as quality check for free 
energy calculations and the discrepancy from zero measures the transformation hysteresis.
50–53
 In 
the selected alchemical transformations for the 3 and 5 series, three and four thermodynamic 
cycle closures were considered. The analysis showed that the maximum discrepancy for the 3 
and 5 series was respectively 0.5±0.2 kcal mol
-1
 (cycle 3B to 3A to 3D in Figure 3A) and -
0.9±0.2 kcal mol
-1
 (cycle 5B to 5A to 5D in Figure 3B). The thermodynamic cycles are reported 
in Figure S1.  
 
Soft-core potentials occasionally introduce serious artefacts  
For the perturbation 3K3B one of the triplicate runs produced a ∆𝐺𝑝𝑟𝑜𝑡(𝟑𝐊 → 𝟑𝐁) value 
that was significantly different from the other two runs and warranted further investigation. 
Extending the per- simulation time to up to 20 ns (Fig 4A) indicated that the free energy 
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gradients were all well converged, apart from the gradients at   = 0.57822 that steadily increases 
with time. Structural analysis of the computed trajectory at this  value (Fig 4B) indicates that a 
pronounced jump in free energy gradients correlates with fusing of a sodium ion with the para 
carbon atom of the decoupled phenyl ring around t = 2.3 ns. Both particles remain fused for the 
rest of the simulation. The phenomenon is illustrated with snapshots in Fig 4C. Further analysis 
indicated that the behavior arose because of a too rapid softening of the Lennard-Jones 
interactions of the perturbed phenyl ring in 3K. This enables particles fusion driven by attractive 
Coulombic interactions between the partial negative charge of the carbon atom and the positive 
charge of the sodium ion. This effect happened only once due to chance diffusion of the sodium 
ion near the phenyl ring, and it can be altogether avoided by adjusting soft core parameters to 
either soften more rapidly with  the Coulombic interactions, or to soften less rapidly with  the 
Lennard-Jones interactions. An alternative could have been to serially turn off partial charges on 
the perturbed phenyl ring, followed by zeroing of Lennard-Jones parameters. Thus this particular 
run was discarded and another repeat of 10 ns was performed. No other soft-core related 
abnormalities were detected in the rest of the dataset.  
 
The free energies of binding are accurate and approach the uncertainties of the experimental 
data 
Table S3 and S4 in the SI reports the relative free energy of binding selecting the ligand 3B or 
5B as reference ligands respectively. For some ligands the calculation of the relative free energy 
of binding was calculated by averaging the relative free energy changes obtained along different 
possible paths in the relative free energy network (Figure 3). For example for the ligand 3E two 
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paths were selected: 𝟑𝐁 → 𝟑𝐃 → 𝟑𝐄 and 𝟑𝐁 → 𝟑𝐂 → 𝟑𝐄. Statistical errors were propagated 
accordingly. 
Next error analysis was undertaken to assert the reliability and relevance of correlations 
between measured and computed free energies of binding. The error analysis results are given in 
Table S5 and Figure 5. The error analysis on the experimental data (Fig 5A) showed that the 
experimental data for the 5 series is more reliable than the 3 series, which shows a noticeable 
spread in R
2
 and PI values. This indicates that uncertainties in the experimental data in the 3 
series limit the maximal correlations that may be realistically achieved. The combined data (3 & 
5) shows an intermediate behavior between the 3 and 5 Series. The error analysis conducted on 
the predicted data (Fig 5B) showed that free energies of binding in both series are predicted with 
similar precision, as evidenced by the high R
2
, PI and low MUE values. The metrics outperform 
the experimental data and thus uncertainties in the predicted data are unlikely to significantly 
affect comparison with experimental data. Turning to comparisons between experimental-
predicted sets (Fig 5C), it is apparent that both datasets give normally distributed R
2
 values with 
an average value slightly over 0.8 when considered as separate data sets while, when combined, 
the average R
2
 drops below 0.7. The MUE values are also normally distributed and the mean 
MUE of the 5 series is lower than for the 3 series. In this case the combined distribution seems to 
settle between the 3 and 5 series distributions. Interestingly the PI distribution is more complex 
and multimodal in the individual series data sets, but follows approximately a normal distribution 
for the combined datasets. This indicates that care should be used when assessing uncertainties 
with this metric since the metric may not be normally or chi-distributed. Figure 6A shows the 
comparison between experimental and computed data combining the two 3 and 5 series. There is 
a clear correlation between the data; however the calculated R
2
 and PI are lower than the same 
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statistical metrics obtained considering the two data sets separately as shown in Figure 6B and 
6C. In Figure 6B the overall agreement is quite satisfactory (R
2 
0.81±0.05), and no significant 
outliers emerge, however, it is apparent that the binding affinity of the larger compounds (e.g. 
3J, 3G, 3H, 3K, 3I) is systematically overestimated and this is reflected by the slope of the 
linear regression (1.6 ± 0.3) between experimental and computed free energies of binding. Figure 
6C similarly shows that the compounds are well ranked and no outliers emerge.  There is also a 
trend, albeit weaker, for overestimation of the free energies of binding of the larger compounds 
(5I, 5J, regression slope 1.3±0.2).  
 
Docking energies overall correlate poorly, but show trends within individual series 
Docking energies are listed in Table S6. Docking energies between multiple repeats were well 
reproducible and uncertainties were taken to be ±0.1 kcal mol
-1
. Comparison of the experimental 
and docking predicted free energies of binding are shown in Figure 7 along with the determined 
R
2
, MUE and PI values. Overall the performance on the combined dataset (Figure 7A) is poorer 
(R
2
 0.34±0.07, MUE 0.85±0.04 and PI 0.61±0.08) than for the molecular simulation results. 
Interestingly correlations with experimental data within individual series are noticeably higher 
(Figure 7B and 7C), although still inferior to the molecular simulation predictions. The main 
reason for the poor combined scoring is that binding affinities of compounds in the 5 series are 
systematically underestimated, as evidenced by the low regression slope value of 0.5±0.1. 
 
Free energy calculations capture trends for positive-coupling between X and R
1
 substituents. 
The computed non-additivity levels for each ligand were next calculated using equation (4). 
Figure 8 reports the obtained results per ligand calculated for the experimental data, the data 
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computed with the Sire-OpenMM molecular simulations, and the data computed with the Vina 
docking calculations. Overall Vina is unable to detect the trend towards positive coupling of the 
X = NH3
+
 and R
1
 groups and the results are scattered around the null hypothesis. By contrast the 
molecular simulations fare much better and statistically significant positive coupling is predicted 
for 8 of the 9 ligands pairs. The compound pair 3F/5F does not show any statistically significant 
non-additive effects.  It is also apparent that the magnitude of the non-additive effects is 
systematically weaker than in the experimental data.  
 
The origin of non-additivity of functional group contributions  
Why do the molecular simulations predict positive coupling between the X=NH3
+
 and R
1
 
groups? Answers were sought via structural analyses of the computed protein-ligand 
conformational ensembles. Baum et al. previously concluded from B-factor analyses of several 
thrombin X-ray structures that formation of the charge-assisted hydrogen-bond with Gly216 
decreases residual mobility of the R
1
 substituents of the 5 series ligands with respect to 3 series 
ligand. A decrease in residual mobility is not expected to contribute to positive coupling, but 
could be a consequence of mutually reinforcing interactions between X and R
1
 groups.   Figure 9 
shows that the experimentally observed  trend is also observed in the present simulations, but 
there are two important exceptions. Compound 5A shows increased flexibility with respect to 
compound 3A (positive <Bfac> value). This compound carries the smallest R
1
 substituent of the 
series (R
1
=H). Compound 5F does not show any change in residual mobility with respect to 
compound 3F. Interestingly 5F is the only compound with no significant computed non-additive 
level (Figure 8). Figure 9 also shows that reduction in ligand mobility correlates with decreases 
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in average distances between the nitrogen atom of the X=NH3
+
 group, and the backbone 
carbonyl of Gly216. Compounds 5A and 5F are again the two exceptions.  
Different hypotheses about the origin of non-additivity have been previously put forward. One 
can speculate that the extra-hydrogen bond with the backbone carbonyl of Gly216 holds the R
1
 
substituents in conformations that pack better with the S3 pocket side-chains.
54
 Alternatively the 
larger R
1
 substituents push the ligand slightly away from the S3 pocket, causing a shortening of 
the hydrogen-bond distances between the extra amino group of the 5 series ligands and the 
backbone carbonyl of Gly216, and one of the ligands amide carbonyl and Gly216 backbone 
NH.
17
  
Clarification was sought by extracting the contribution of protein-ligand interaction energies to 
the non-additivity levels from the computed trajectories (equation 6). The thrombin binding site 
was partitioned in four groups that contact different sections of the ligands (Figure 10A). Figure 
10B shows that there is no strong correlation between changes in ligand interaction energies with 
S3/S4 pocket residues and computed non-additivity levels. 5K is the only ligand that shows 
weak but statistically significant enhanced lipophilic contacts. Figure 10B also shows that all 5 
series ligands apart from 5A, 5F and 5J exhibit enhanced interactions with Gly216. This was 
expected for 5A and 5F in light of the changes in average hydrogen-bond distances shown in 
Figure 9. For 5J favorable contributions of protein-ligand interaction energies to the computed 
non-additivity level cannot be detected owing to high statistical errors. This was already reflected 
by the relatively high uncertainties in the computed non-additivity level for this compound 
(Figure 8).  Remarkably, Figure 10B also shows that ligand 5F is the only compound that 
exhibits enhanced interactions with S2 pocket residues His57, Tyr60A and Trp60D. These 
interactions occur via packing of the ligand pyrrolidine ring. All other ligands show a trend for 
 20 
weakened interactions with this group of protein residues, but the trend is significant only for 5E, 
5H and 5I. Lastly Figure 10B also shows that contacts with residues in the S1 pocket also 
contribute favorably to the binding of 5H, 5I but disfavor 5F. That is, the trend is the reverse of 
what was observed for interactions with S2 pocket residues. 
The picture that emerges is that anchoring of the 5 series ligands via formation of the hydrogen 
bond between the X group and Gly216 does not strengthen lipophilic contact between R
1
 groups 
and the S3/S4 pocket residues. However, an increase in the size of the R
1
 substituent does 
generally contribute to an energetically favorable shortening of hydrogen-bonding distances 
between the X group and the backbone carbonyl of Gly216. Nevertheless, it is misleading to 
ascribe all non-additivity to this single interaction since weakened interactions are also observed 
with S2 pocket residues, and enhanced interactions are observed with S1 pocket residues. For 
compound 5F, the opposite happens, that is weakened interactions with S1, S3/S4 pockets 
residues, and enhanced interactions with S2 pocket residues. This is achieved by small 
readjustments of 5F and binding site residues, which is sufficient to abrogate positive coupling 
between X =NH3
+
 and R
1
=i-Butyl groups. 
For 5A the above explanation is unsatisfactory since this compound lacks any substituent 
interacting with the S3 pocket, does not exhibit statistically significant changes in protein-ligand 
interaction energies (Figure 10B), and yet shows significant non-additivity in both experiments 
and simulations (Figure 8). The data in Figure 9 suggests that enhanced residual mobility of 5A 
when bound to thrombin may contribute to non-additivity. More quantitative statements about 
entropic contributions to non-additivity for 5A were not pursued owing to the difficulties 
encountered in accurately evaluating entropic changes and partitioning entropy into meaningful 
components.
18
 The analysis presented in Figure 10 could have been extended to other 
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components of the potential energy function, for instance changes in hydration enthalpies have 
been proposed to contribute to non-additivity in some protein-ligand complexes,
55
 and these 
could be computed using molecular simulation trajectory analyses methodologies.
56–58
 However, 
exploratory calculations suggest that converging hydration energy components to a level of 
precision sufficient to enable meaningful comparison between ligands will require significantly 
longer simulations than what was achieved here. Nevertheless it is now clear from the data 
depicted in Figure 10B that a profound understanding of non-additive effects in this system 
requires consideration of interactions occurring across the entire thrombin binding site.  
 
Conclusion  
In summary the alchemical free energy calculation protocols used here could accurately predict 
the relative free energies of binding of two congeneric series of thrombin ligands. Evidence for 
statistically significant non-additivity of interaction energies between hydrophobic groups R
1 
and 
the polar group X=NH3
+
 was obtained, which required aggregated molecular dynamics sampling 
time of ca. 10 s. The experimentally observed trend for positive coupling between these two 
groups was reproduced for all compounds but 5F, albeit with a weaker magnitude. Further work 
is needed to establish why 5F is an outlier. This could be pursued for instance by evaluating 
whether the results for 5F are an artefact of the particular ligand force-field use here. 
 Although docking protocols were also successful at correlating docking energies with binding 
affinities within individual ligand series, a much poorer correlation was obtained when ranking 
both series together. This is because the docking protocol was unable to capture any coupling 
between interactions of the R
1
 and X groups. This suggests that non-additive effects in this 
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dataset originate from changes in solvation and/or dynamics, which are accounted for explicitly 
in the molecular simulation, but largely lacking in docking calculations. 
 Analysis of the computed molecular simulation trajectories suggests that changes in contacts 
between R
1
 groups and S3/S4 pocket residues is not a major contribution to the observed positive 
coupling. However, shortening of hydrogen-bonding distances between the ligands and Gly216 
is an important source of non-additivity, as was suggested earlier.
17
 Yet changes in this 
interaction do not explain all observed non-additivity levels, and other changes in interactions 
with protein residues occur across the entire binding site. Therefore coupling between the 
X=NH3
+
 and R
1
 substituents is the result of an energetic balance between numerous interactions, 
whose final outcome depends non-trivially on the precise chemical nature of R
1
.  
Should we be surprised? While we ultimately hope for models that produce simple actionable 
ligand design guidelines, Nature is not concerned with the partitioning of protein-ligand 
interactions into components that satisfy human intuition. While there may not be a simple 
explanation to the origin of non-additivity of protein-ligand interactions for the compounds 
investigated here, it is gratifying that modern potential energy functions and molecular 
simulation protocols have achieved the precision and accuracy needed to capture this 
phenomenon.  
ASSOCIATED CONTENT 
Supporting Information.  
Table of estimated Gwat(AB), ∆Gprot(AB) and Gbind (AB) values for each 
perturbation. Cycle closure errors. Table of estimated free energies of binding relative to 
reference compounds 3B and 5B. Table of uncertainties for the dataset correlation metrics. Table 
 23 
of docking predicted binding free energies. Instructions to download all input files for the Sire-
OpenMM calculations.  
AUTHOR INFORMATION 
Corresponding Author 
* E-mail: mail@julienmichel.net Phone number: +44 (0)131 650 4797 
Current Address: 
‖ Gaetano Calabrò - Pharmaceutical Department, University of California Irvine, Irvine, CA 
92697 USA.  
‖ Francis Powlesland - IBM  76/78 Upper Ground, London, SE1 9PZ, UK 
Notes 
The authors declare no competing financial interest. 
ACKNOWLEDGMENTS 
J.M. is supported by a Royal Society University Research Fellowship. The research leading to 
these results has received funding from the European Research Council under the European 
Union’s Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement No. 336289. 
This research was supported by a NVIDIA academic partnership. Parts of the simulations were 
performed using the Supercomputing Service Blue Crystal at the University of Bristol 
(https://www.acrc.bris.ac.uk). This research was supported by CCP-BioSim via travel grants to 
G. C. CCP-BioSim is funded by the EPSRC (EP/J010588/1). C. J. W. acknowledges support of 
 24 
BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre (BB/L01386X/1) and the 
BBSRC (BB/K016601/1). 
References 
 
 
(1)  Heald, R.; Bowman, K. K.; Bryan, M. C.; Burdick, D.; Chan, B.; Chan, E.; Chen, Y.; 
Clausen, S.; Dominguez-Fernandez, B.; Eigenbrot, C.; et al. Noncovalent Mutant 
Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. 
J. Med. Chem. 2015, 58 (22), 8877–8895. 
(2)  Smith, A. J. T.; Zhang, X.; Leach, A. G.; Houk, K. N. Beyond Picomolar Affinities: 
Quantitative Aspects of Noncovalent and Covalent Binding of Drugs to Proteins. J. Med. 
Chem. 2009, 52 (2), 225–233. 
(3)  Whitesides, G. M.; Krishnamurthy, V. M. Designing Ligands to Bind Proteins. Q. Rev. 
Biophys. 2005, 38 (4), 385–395. 
(4)  Bissantz, C.; Kuhn, B.; Stahl, M. A Medicinal Chemist’s Guide to Molecular Interactions. 
J. Med. Chem. 2010, 53 (14), 5061–5084. 
(5)  Freire, E. Do Enthalpy and Entropy Distinguish First in Class from Best in Class? Drug 
Discov. Today 2008, 13 (19-20), 869–874. 
(6)  Ruben, A. J.; Kiso, Y.; Freire, E. Overcoming Roadblocks in Lead Optimization: A 
Thermodynamic Perspective. Chem. Biol. Drug Des. 2006, 67 (1), 2–4. 
(7)  Chaires, J. B. Calorimetry and Thermodynamics in Drug Design. Annu. Rev. Biophys. 2008, 
37 (1), 135–151. 
(8)  Bravi, G.; Gancia, E.; Green, D. V. S.; Hann, M. M. Modelling Structure-Activity 
Relationships. In Virtual Screening for Bioactive Molecules; Böhm, H.-J., Schneider, G., 
Eds.; Wiley-VCH Verlag GmbH, 2000; pp 81–116. 
(9)  Agrafiotis, D. K.; Bandyopadhyay, D.; Wegner, J. K.; van Vlijmen, H. Recent Advances in 
Chemoinformatics. J. Chem. Inf. Model. 2007, 47 (4), 1279–1293. 
(10)  Kenny, P. W.; Sadowski, J. Structure Modification in Chemical Databases. In 
Chemoinformatics in Drug Discovery; Oprea, T. I., Ed.; Wiley-VCH Verlag GmbH & Co. 
KGaA, 2005; pp 271–285. 
(11)  Free, S. M.; Wilson, J. W. A Mathematical Contribution to Structure-Activity Studies. J. 
Med. Chem. 1964, 7 (4), 395–399. 
(12)  Hansch, C. Quantitative Approach to Biochemical Structure-Activity Relationships. Acc. 
Chem. Res. 1969, 2 (8), 232–239. 
(13)  Mark, A. Decomposition of the Free Energy of a System in Terms of Specific Interactions 
Implications for Theoretical and Experimental Studies. J. Mol. Biol. 1994, 240 (2), 167–
176. 
(14)  Dill, K. A. Additivity Principles in Biochemistry. J. Biol. Chem. 1997, 272 (2), 701–704. 
(15)  van Gunstener, W. F.; Beutler, T. C.; Fraternali, F.; King, P. M.; Mark, A. E.; Smith, P. E. 
Computation of Free Energy in Practice: Choice of Approximations and Accuracy 
Limiting Factors; Computer Simulation of Biomolecular Systems, theoretical and 
experimental applications.; Escom Science, 1993; Vol. 2. 
 25 
(16)  Patel, Y.; Gillet, V. J.; Howe, T.; Pastor, J.; Oyarzabal, J.; Willett, P. Assessment of 
Additive/Nonadditive Effects in Structure−Activity Relationships: Implications for 
Iterative Drug Design. J. Med. Chem. 2008, 51 (23), 7552–7562. 
(17)  Baum, B.; Muley, L.; Smolinski, M.; Heine, A.; Hangauer, D.; Klebe, G. Non-Additivity of 
Functional Group Contributions in Protein–Ligand Binding: A Comprehensive Study by 
Crystallography and Isothermal Titration Calorimetry. J. Mol. Biol. 2010, 397 (4), 1042–
1054. 
(18)  Michel, J. Current and Emerging Opportunities for Molecular Simulations in Structure-
Based Drug Design. Phys. Chem. Chem. Phys. 2014, 16 (10), 4465–4477. 
(19)  Woods, C. J.; Malaisree, M.; Michel, J.; Long, B.; McIntosh-Smith, S.; Mulholland, A. J. 
Rapid Decomposition and Visualisation of Protein–ligand Binding Free Energies by 
Residue and by Water. Faraday Discuss. 2014, 169 (0), 477–499. 
(20)  Schrödinger Release 2011-1: Maestro, Version 9.2, Schrödinger, LLC, New York, NY, 
2011. 
(21)  Ko, J.; Dongseon Lee, H. P.; Evangelos Coutsias, J. L.; Seok, C. The FALC-Loop Web 
Server for Protein Loop Modeling. Nucleic Acids Res. 2011, 39 (2), 210–214. 
(22)  Loeffler, H. H.; Michel, J.; Woods, C. FESetup: Automating Setup for Alchemical Free 
Energy Simulations. J. Chem. Inf. Model. 2015, 55 (12), 2485–2490. 
(23)  Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and 
Testing of a General Amber Force Field. J. Comput. Chem. 2004, 25 (9), 1157–1174. 
(24)  Jakalian, A.; Bush, B. L.; Jack, D. B.; Bayly, C. I. Fast, Efficient Generation of High-
Quality Atomic Charges. AM1-BCC Model: I. Method. J. Comput. Chem. 2000, 21 (2), 
132–146. 
(25)  Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and 
Testing of a General Amber Force Field. J. Comput. Chem. 2005, 26 (1), 114–114. 
(26)  Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. 
Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 
1983, 79 (2), 926–935. 
(27)  Aaqvist, J. Ion-Water Interaction Potentials Derived from Free Energy Perturbation 
Simulations. J. Phys. Chem. 1990, 94 (21), 8021–8024. 
(28)  Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C. Comparison 
of Multiple Amber Force Fields and Development of Improved Protein Backbone 
Parameters. Proteins 2006, 65 (3), 712–725. 
(29)  Michel, J.; Essex, J. Prediction of Protein-Ligand Binding Affinity by Free Energy 
Simulations: Assumptions, Pitfalls and Expectations. J. Comput. Aided Mol. Des. 2010, 24 
(8), 639–658. 
(30)  Michel, J.; Foloppe, N.; Essex, J. W. Rigorous Free Energy Calculations in Structure-Based 
Drug Design. Mol. Inform. 2010, 29 (8-9), 570–578. 
(31)  Woods, C. J.; Calabro, G.; Michel, J. Sire Molecular Simulation Framework, Revision 
2270, Http://siremol.org/ (Accessed May 19, 2016). 
(32)  Eastman, P.; Pande, V. S. OpenMM: A Hardware-Independent Framework for Molecular 
Simulations. Comput. Sci. Eng. 2010, 12 (4), 34–39. 
(33)  Rovigatti, L.; Šulc, P.; Reguly, I. Z.; Romano, F. A Comparison between Parallelization 
Approaches in Molecular Dynamics Simulations on GPUs. J. Comput. Chem. 2015, 36 
(1), 1–8. 
 26 
(34)  Davis, J. E.; Ozsoy, A.; Patel, S.; Taufer, M. Towards Large-Scale Molecular Dynamics 
Simulations on Graphics Processors. In Bioinformatics and Computational Biology; 
Rajasekaran, S., Ed.; Lecture Notes in Computer Science; Springer Berlin Heidelberg, 
2009; pp 176–186. 
(35)  Xu, D.; Williamson, M. J.; Walker, R. C. Advancements in Molecular Dynamics 
Simulations of Biomolecules on Graphical Processing Units. In Annual Reports in 
Computational Chemistry; Wheeler, R. A., Ed.; Elsevier, 2010; Vol. 6, pp 2–19. 
(36)  Shyu, C.; Ytreberg, M. Reducing the Bias and Uncertainty of Free Energy Estimates by 
Using Regression to Fit Thermodynamic Integration Data. J. Comput. Chem. 2009, 30 
(14), 2297–2304. 
(37)  Michel, J.; Verdonk, M.; Essex, J. Protein-Ligand Complexes: Computation of the Relative 
Free Energy of Different Scaffolds and Binding Modes. J Chem Theory Comput 2007, 3, 
1645–1655. 
(38)  Kirkwood, J. Statistical Mechanics of Fluid Mixtures. J. Chem. Phys. 1935, 3 (5), 300–313. 
(39)  Kirkwood, J. G. Theory of Liquids; Gordon and Breach, 1968. 
(40)  Mezei, M. The Finite Difference Thermodynamic Integration, Tested on Calculating the 
Hydration Free Energy Difference between Acetone and Dimethylamine in Water. J. 
Chem. Phys. 1987, 86 (12), 7084–7088. 
(41)  Zwanzig, R. High-Temperature Equation of State by a Perturbation Method. I. Nonpolar 
Gases. J. Chem. Phys. 1954, 22 (8), 1420–1426. 
(42)  Chow, K.-H.; Ferguson, D. M. Isothermal-Isobaric Molecular Dynamics Simulations with 
Monte Carlo Volume Sampling. Comput. Phys. Commun. 1995, 91 (1–3), 283–289. 
(43)  Åqvist, J.; Wennerström, P.; Nervall, M.; Bjelic, S.; Brandsdal, B. O. Molecular Dynamics 
Simulations of Water and Biomolecules with a Monte Carlo Constant Pressure Algorithm. 
Chem. Phys. Lett. 2004, 384 (4–6), 288–294. 
(44)  Andersen, H. C. Molecular Dynamics Simulations at Constant Pressure And/or 
Temperature. J. Chem. Phys. 1980, 72 (4), 2384–2393. 
(45)  Barker, J. A.; Watts, R. O. Monte Carlo Studies of the Dielectric Properties of Water-like 
Models. Mol. Phys. 1973, 26 (3), 789–792. 
(46)  Fernández, D. P.; Mulev, Y.; Goodwin, A. R. H.; Sengers, J. M. H. L. A Database for the 
Static Dielectric Constant of Water and Steam. J. Phys. Chem. Ref. Data 1995, 24 (1), 33–
70. 
(47)  Brown, S. P.; Muchmore, S. W.; Hajduk, P. J. Healthy Skepticism: Assessing Realist ic 
Model Performance. Drug Discov. Today 2009, 14 (7-8), 420–427. 
(48)  Luccarelli, J.; Michel, J.; Tirado-Rives, J.; Jorgensen, W. L. Effects of Water Placement on 
Predictions of Binding Affinities for p38α MAP Kinase Inhibitors. J. Chem. Theory 
Comput. 2010, 6 (12), 3850–3856. 
(49)  Trott, O.; Olson, A. J. AutoDock Vina: Improving the Speed and Accuracy of Docking with 
a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 
2010, 31 (2), 455–461. 
(50)  Chipot, C. Free Energy Calculations: Theory and Applications in Chemistry and Biology 
(Springer Series in Chemical Physics); Springer, 2007. 
(51)  Michel, J.; Tirado-Rives, J.; Jorgensen, W. L. Energetics of Displacing Water Molecules 
from Protein Binding Sites: Consequences for Ligand Optimization. J. Am. Chem. Soc. 
2009, 131 (42), 15403–15411. 
 27 
(52)  Michel, J.; Verdonk, M. L.; Essex, J. W. Protein-Ligand Binding Affinity Predictions by 
Implicit Solvent Simulations:  A Tool for Lead Optimization? J. Med. Chem. 2006, 49 
(25), 7427–7439. 
(53)  Mishra, S. K.; Calabró, G.; Loeffler, H. H.; Michel, J.; Koča, J. Evaluation of Selected 
Classical Force Fields for Alchemical Binding Free Energy Calculations of Protein-
Carbohydrate Complexes. J. Chem. Theory Comput. 2015, 11 (7), 3333–3345. 
(54)  Muley, L.; Baum, B.; Smolinski, M.; Freindorf, M.; Heine, A.; Klebe, G.; Hangauer, D. G. 
Enhancement of Hydrophobic Interactions and Hydrogen Bond Strength by Cooperativity: 
Synthesis, Modeling, and Molecular Dynamics Simulations of a Congeneric Series of 
Thrombin Inhibitors. J. Med. Chem. 2010, 53 (5), 2126–2135. 
(55)  Biela, A.; Betz, M.; Heine, A.; Klebe, G. Water Makes the Difference: Rearrangement of 
Water Solvation Layer Triggers Non-Additivity of Functional Group Contributions in 
Protein–Ligand Binding. ChemMedChem 2012, 7 (8), 1423–1434. 
(56)  Gerogiokas, G.; Calabro, G.; Henchman, R. H.; Southey, M. W. Y.; Law, R. J.; Michel, J. 
Prediction of Small Molecule Hydration Thermodynamics with Grid Cell Theory. J. 
Chem. Theory Comput. 2014, 10 (1), 35–48. 
(57)  Michel, J.; Henchman, R. H.; Gerogiokas, G.; Southey, M. W. Y.; Mazanetz, M. P.; Law, 
R. J. Evaluation of Host–Guest Binding Thermodynamics of Model Cavities with Grid 
Cell Theory. J. Chem. Theory Comput. 2014, 10 (9), 4055–4068. 
(58)  Gerogiokas, G.; Southey, M. W. Y.; Mazanetz, M. P.; Hefeitz, A.; Bodkin, M.; Law, R. J.; 
Michel, J. Evaluation of Water Displacement Energetics in Protein Binding Sites with 
Grid Cell Theory. Phys. Chem. Chem. Phys. 2015, 17 (13), 8416–8426. 
 
 
 
 
  
 28 
 
Figure 1. A) Depiction of the thrombin-ligand complexes considered in this study. The main 
protein residues involved in interactions with the ligands are shown. Figure adapted from Baum 
et al.
17
 (B) Histogram of the experimental free energy of binding relative to compound B for 
series 3 and series 5 compounds with equivalent R
1
 groups. It is apparent that the relative free 
energy of binding of series 5 ligands is more negative than for series 3 ligands. The ligand names 
are those used by Baum et al. 
17
 paper. Ligand G in the 3 series maps to ligand H in the 5 series, 
while ligand H in the 3 series maps to ligand I in the 5 series.  
  
 29 
 
 
Figure 2. The ligand 5R’’ presents both the modifications of the ligands 5R’ and 3R’'. 
Therefore, the non-additivity NA can be evaluated calculating the difference between the relative 
free energy of binding ∆∆𝐺(5R′→5R'') and ∆∆𝐺(3R′→3R''). 
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Figure 3. The network of relative free energy calculations map used to determine the free energy 
of binding of A) series 3 and B) series 5 ligands with respect to reference compounds 3B and 5B. 
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Figure 4. The perturbation 3K→3B presented unusual convergence behavior in one of the 
triplicate runs of the protein-ligand complex. A) Extending the per- duration of the simulations 
from 5 ns to up to 20 ns demonstrated high convergence of free energy gradients apart from λ = 
0.57822 where the gradients steadily increase with time. B) A plot of the distance between one 
sodium Na+ and the para carbon atom of the decoupled phenyl ring indicates that the ion 
overlaps with the carbon atom after ca. 2.3 ns, and this correlates with a jump in the free energy 
gradient. C) Snapshots sampled from the simulation around 2.3 ns. 
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Figure 5. The computed Probability Distribution Functions (PDF) for R
2
, MUE and PI metrics 
of the 3, 5 Series and combining them (3 & 5 Series). A) Experimental-Experimental pairing. B) 
Predicted-Predicted pairing. C) Experimental-Predicted pairing. 
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Figure 6. Comparison of measured and molecular simulations predicted relative free energies of 
binding. A) 3 & 5 Series combined. B) 3 Series and C) 5 Series. The free energies of binding are 
relative to ligand 3B or 5B. R
2
, MUE and PI metrics and uncertainty intervals are also plotted, 
along with a linear regression slope and intercept (dashed-line). The solid line has slope 1 and 
intercept 0.  
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Figure 7. Comparison of measured and docking predicted relative free energies of binding. A) 3 
& 5 Series combined. B) 3 Series and C) 5 Series. The free energies of binding are relative to 
ligand 3B or 5B 
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Figure 8. Comparison of non-additivity levels of the relative free energies of binding for 
experimental data (blue), Sire-OpenMM predicted free energies of binding (red), and Vina 
predicted free energies of binding (green). Note that ligands G and H in 3 series map 
respectively to ligands H and I of series 5. 
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Figure 9. Changes in average B-factors of R
1
 atoms of 5 series ligand with respect to 3 series 
ligands (red), and changes in average hydrogen-bond distance between X=NH3+ and the 
backbone carbonyl of Gly216 of 5 series ligands with respect to ligand 5B (blue). Error bars 
denote one standard error of the mean. 
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Figure 10. Contribution of protein-ligand interaction energy components to non-additivity 
levels. A) The thrombin binding site was decomposed in four regions. B) The computed non 
additivity levels are represented in pink. Other histograms indicate the contributions of protein-
ligand interactions energies to non-additivity levels from the S3/S4 pocket group (red), from 
Gly216 (green), from the S2 pocket group (yellow), S1 pocket group (light blue). Error bars 
denote one standard error of the mean. For clarity only contributions that deviate from 0 kcal 
mol
-1
 by at least one standard error are shown. 
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